Skip to main content
. 2011 Jun 10;286(31):27425–27435. doi: 10.1074/jbc.M111.249656

TABLE 1.

Clinical and laboratory characteristics of TPP and SPP patients

TPP SPP
Number 120 60
Age 29 ± 6 25 ± 8
Male:Female 116:4 60:0

Plasma
    K+ (3.5–5.1 mEq/liter) 2.1 ± 0.2 2.2 ± 0.2
    T3 (86–187 ng/dl) 334 ± 91a 124 ± 30
    fT4 (0.8–2.0 ng/dl) 4.0 ± 1.1a 1.1 ± 0.4
    TSH (0.35–5.0 μU/liter) <0.03a 2.3 ± 1.0
    Na+ (136–142 mEq/ iter) 141 ± 2 142 ± 5
    Cl (98–106 mEq/liter) 106 ± 2 103 ± 8
    Phosphate (2.6–4.6 mg/dl) 2.0 ± 0.5a 2.6 ± 0.7
    Ionized calcium (4.5–5.3 mg/dl) 4.8 ± 0.2 4.7 ± 0.2
    Magnesium (1.7–2.4 mg/dl) 1.8 ± 0.3 2.0 ± 0.4
    Urea nitrogen (12–20 mg/dl) 12 ± 3 12 ± 6
    Creatinine (Cr) (0.7–1.2 mg/dl) 0.7 ± 0.2a 1.0 ± 0.3

Urine
    K+ (mEq/liter) 9 ± 4 11 ± 5
    Creatinine (mg/dl) 108 ± 32 112 ± 37
    TTKG 2.4 ± 0.9 2.1 ± 0.4

a p < 0.05.